HYPERION DEFI, INC. Retained Earnings
HYPERION DEFI, INC. (HYPD) had Retained Earnings of -$200.83 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$200.83M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$231.78M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$240.62M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$200.86M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$200.83M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$231.78M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$240.62M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$200.86M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$207.48M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$198.79M 10-Q · filed 2025-05-19 |
| 2024-12-31 | -$195.31M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$175.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$167.47M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$156.41M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$145.49M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$137.52M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$130.19M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$123.97M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$118.23M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$112.11M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$104.80M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$97.56M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$90.22M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$93.20M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$87.63M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$82.79M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$77.44M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$73.23M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$68.14M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$63.12M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$57.67M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$52.43M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$47.78M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$42.45M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$36.51M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$30.33M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$26.01M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$22.69M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$19.26M 10-K · filed 2019-03-27 |
| 2016-12-31 | -$14.13M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |